Cargando…

Verifying Elimination Programs with a Special Emphasis on Cysticercosis Endpoints and Postelimination Surveillance

Methods are needed for determining program endpoints or postprogram surveillance for any elimination program. Cysticercosis has the necessary effective strategies and diagnostic tools for establishing an elimination program; however, tools to verify program endpoints have not been determined. Using...

Descripción completa

Detalles Bibliográficos
Autores principales: Handali, Sukwan, Pawitan, Yudi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505642/
https://www.ncbi.nlm.nih.gov/pubmed/23213490
http://dx.doi.org/10.1155/2012/974950
_version_ 1782250788255432704
author Handali, Sukwan
Pawitan, Yudi
author_facet Handali, Sukwan
Pawitan, Yudi
author_sort Handali, Sukwan
collection PubMed
description Methods are needed for determining program endpoints or postprogram surveillance for any elimination program. Cysticercosis has the necessary effective strategies and diagnostic tools for establishing an elimination program; however, tools to verify program endpoints have not been determined. Using a statistical approach, the present study proposed that taeniasis and porcine cysticercosis antibody assays could be used to determine with a high statistical confidence whether an area is free of disease. Confidence would be improved by using secondary tests such as the taeniasis coproantigen assay and necropsy of the sentinel pigs.
format Online
Article
Text
id pubmed-3505642
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-35056422012-12-04 Verifying Elimination Programs with a Special Emphasis on Cysticercosis Endpoints and Postelimination Surveillance Handali, Sukwan Pawitan, Yudi J Parasitol Res Research Article Methods are needed for determining program endpoints or postprogram surveillance for any elimination program. Cysticercosis has the necessary effective strategies and diagnostic tools for establishing an elimination program; however, tools to verify program endpoints have not been determined. Using a statistical approach, the present study proposed that taeniasis and porcine cysticercosis antibody assays could be used to determine with a high statistical confidence whether an area is free of disease. Confidence would be improved by using secondary tests such as the taeniasis coproantigen assay and necropsy of the sentinel pigs. Hindawi Publishing Corporation 2012 2012-11-14 /pmc/articles/PMC3505642/ /pubmed/23213490 http://dx.doi.org/10.1155/2012/974950 Text en Copyright © 2012 S. Handali and Y. Pawitan. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Handali, Sukwan
Pawitan, Yudi
Verifying Elimination Programs with a Special Emphasis on Cysticercosis Endpoints and Postelimination Surveillance
title Verifying Elimination Programs with a Special Emphasis on Cysticercosis Endpoints and Postelimination Surveillance
title_full Verifying Elimination Programs with a Special Emphasis on Cysticercosis Endpoints and Postelimination Surveillance
title_fullStr Verifying Elimination Programs with a Special Emphasis on Cysticercosis Endpoints and Postelimination Surveillance
title_full_unstemmed Verifying Elimination Programs with a Special Emphasis on Cysticercosis Endpoints and Postelimination Surveillance
title_short Verifying Elimination Programs with a Special Emphasis on Cysticercosis Endpoints and Postelimination Surveillance
title_sort verifying elimination programs with a special emphasis on cysticercosis endpoints and postelimination surveillance
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505642/
https://www.ncbi.nlm.nih.gov/pubmed/23213490
http://dx.doi.org/10.1155/2012/974950
work_keys_str_mv AT handalisukwan verifyingeliminationprogramswithaspecialemphasisoncysticercosisendpointsandposteliminationsurveillance
AT pawitanyudi verifyingeliminationprogramswithaspecialemphasisoncysticercosisendpointsandposteliminationsurveillance